Diagnostic regulatory pathways are an underrecognized bottleneck in precision oncology clinical trials: Real-world evidence across Europe
European Journal of Cancer · 2026
DOI: 10.1016/j.ejca.2026.117009 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026. Verfasst von Sarah Hersey und 6 weiteren Autor:innen. Beteiligte Einrichtung: Johnston Cancer Research Centre, Queen's University Belfast, School of Medicine, Dentistry & Biomedical Sciences, Belfast, Ireland, UK; Bristol Myers…. Hauptthemen laut MEDLINE: Precision Medicine, Clinical Trials as Topic, Biomarkers, Tumor, Neoplasms. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Higher Education Authority, Health Data Research UK.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Johnston Cancer Research Centre, Queen's University Belfast, School of Medicine, Dentistry & Biomedical Sciences, Belfast, Ireland, UK; Bristol Myers Squibb, Lawrenceville, NJ, USA. Electronic address: Sarah.hersey@bms.…
- Bristol Myers Squibb, Lawrenceville, NJ, USA.
- Wyss Institute, Harvard, Boston, MA, USA.
- Johnston Cancer Research Centre, Queen's University Belfast, School of Medicine, Dentistry & Biomedical Sciences, Belfast, Ireland, UK; Future Medicines Institute, Queen's University Belfast, Belfast, Ireland, UK.
- Diaceutics PLC, Belfast, Ireland, UK.
- Johnston Cancer Research Centre, Queen's University Belfast, School of Medicine, Dentistry & Biomedical Sciences, Belfast, Ireland, UK.
Förderung
- Higher Education Authority
- Health Data Research UK
Zitieren
APA
Hersey, S., Celik, H., Rosen, S., Scott, C., Keeling, P., Joglekar, L., & Lawler, M. (2026). Diagnostic regulatory pathways are an underrecognized bottleneck in precision oncology clinical trials: Real-world evidence across Europe. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2026.117009
Vancouver
Hersey S, Celik H, Rosen S, Scott C, Keeling P, Joglekar L, et al. Diagnostic regulatory pathways are an underrecognized bottleneck in precision oncology clinical trials: Real-world evidence across Europe. European Journal of Cancer. 2026. doi:10.1016/j.ejca.2026.117009
BibTeX
@article{Hersey2026,
author = {Hersey, Sarah and Celik, Haydar and Rosen, Steven and Scott, Christopher and Keeling, Peter and Joglekar, Laura and Lawler, Mark},
title = {Diagnostic regulatory pathways are an underrecognized bottleneck in precision oncology clinical trials: Real-world evidence across Europe},
journal = {European Journal of Cancer},
year = {2026},
doi = {10.1016/j.ejca.2026.117009}
}
EUVIMED